Table of Contents
| << Previous Issue | Jan 2007 (Vol: 2007, Issue: 79) | Next Issue >> |
- Section: Business Commentaries
-
Where Now for Biotech?
- Section: Cartoons
-
Insomnia
- Section: Deal Trackers
-
Provenge (Sipuleucel-T)
- Section: Features
-
Technology Focus: Antibodies - End of the Boom?
-
A Partnership between Little and Large
-
Product Enhancement: Halozyme and Roche Link
-
GlaxoSmithKline Acquires Next-Generation Antibody Company Domantis
- Section: General
-
Drug Withdrawals: Pfizer the Latest Victim
-
Graffinity Pharmaceuticals GmbH
-
Santhera Pharmaceuticals AG
- Section: Licensing
-
Protherics’ DigiFab™ to Become Market Leader in Europe
- Section: Mergers & Acquisitions
-
Vectura to Take Over Innovata
-
Actavis Acquires Abrika and ZiO Zdorovje
- Section: Research & Development
-
CDC Awards US$11.4 M to Develop Avian Influenza Tests
-
R&D in the Alzheimer’s Field
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS